Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade

References

• Basu S, Totty NF, Irwin MS, Sudol M, Downward J. 2003. Akt phosphorylates the yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Molecular Cell. 11(1):11–23.
   PubMed Web of Science ®Google Scholar
• Beffagna G, Sacchetto R, Cavicchioli L, Sammarco A, Mainenti M, Ferro S, Trez D, Zulpo M, Michieletto S, Cecchinato A, et al. 2016. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours. Vet J. 207:105–111.
   PubMed Web of Science ®Google Scholar
• Bisso A, Filipuzzi M, Gamarra Figueroa GP, Brumana G, Biogioni F, Doni M, Cecotti G, Tanaskovic N, Morelli MJ, Pendino V, et al. 2020. Cooperation between MYC and beta-catenin in liver tumorigenesis requires Yap/TAZ. Hepathology. 72(4): 430–1443.
   PubMed Web of Science ®Google Scholar
• Bonilla X, Parmentier L, King B, Bezrukov F, Kaya G, Zoete V, Seplyarskiy VB, Sharpe HJ, McKee T, Letourneau A, et al. 2016. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nat Genet. 48(4):398–406.
   PubMed Web of Science ®Google Scholar
• Brinkhof B, Spee B, Rothuizen J, Penning LC. 2006. Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal Biochem. 356(1):36–43.
   PubMed Web of Science ®Google Scholar
• Bustin S, Penning LC. 2012. Improving the analysis of quantitative PCR data in veterinary research. Vet J. 191(3):279–81.
   PubMed Web of Science ®Google Scholar
• Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, Olsvik PA, Penning LC, Toegel S. 2010. MIQE-precise: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol. 11(1):74.
   PubMed Web of Science ®Google Scholar
• Callus BA, Verhagen AM, Vaux DL. 2006. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C‐terminal coiled‐coil domains, leads to its stabilization and phosphorylation. FEBS J. 273(18):4264–4276.
   PubMed Web of Science ®Google Scholar
• Cao X, Zhao B. 2019. Quantitative real-time PCR to measure YAP/TAZ activity in human cells. Meth Mol Biol. 1893:137–152.
   PubMedGoogle Scholar
• Chan EHY, Nousiainen M, Chalamalasetty RB, Schäfer A, Nigg EA, Silljé HHW. 2005. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 24(12):2076–2086.
   PubMed Web of Science ®Google Scholar
• Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, et al. 2011. The hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 147(4):759–772.
   PubMed Web of Science ®Google Scholar
• Corvaisier M, Bauzone M, Corfiotti F, Renaud F, Amrani ME, Monté D, Truant S, Leteurtre E, Formstecher P, Van Seuningen I, et al. 2016. Regulation of cellular quiescence by YAP/TAZ and cyclin E1 in colon cancer cells: implication in chemoresistance and cancer relapse. Oncotarget. 7(35):56699–56712.
   PubMedGoogle Scholar
• Ge M, Liu H, Zhang Y, Li N, Zhao S, Zhao W, Zhen Y, Yu J, He H, Shao R‐g. 2017. The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. Br J Pharmacol. 174(10):1147–1160.
   PubMed Web of Science ®Google Scholar
• Genevet A, Tapon N. 2011. The Hippo pathway and apico–basal cell polarity. Biochem J. 436(2):213–224.
   PubMedGoogle Scholar
• Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, Zider A. 2008. SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Current Biology. 18(6):435–441.
   PubMed Web of Science ®Google Scholar
• Guillemette S, Rico C, Godin P, Boerboom D, Paquet M. 2017. In vitro validation of the Hippo pathway as a pharmacological target for canine mammary gland tumors. J Mammary Gland Biol Neoplasia. 22(3):203–214.
   PubMed Web of Science ®Google Scholar
• Haak AJ, Kostallari E, Sicard D, Ligresti G, Choi KM, Caporarello N, Jones DL, Tan Q, Meridew J, Espinosa AMD, Aravamudhan A, Maiers JL, et al. 2019. Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis. Sci Transl Med. 11(516):eaau6296.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell. 144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Harvey KF, Pfleger CM, Hariharan IK. 2003. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell. 114(4):457–467.
   PubMed Web of Science ®Google Scholar
• Heng BC, Zhang X, Aubel D, Bai Y, Li X, Wei Y, Fussenegger M, Deng X. 2020. Role of YAP/TAZ in cell lineage fate determination and related signaling pathways. Front Cell Dev Biol. 8:735.
   PubMed Web of Science ®Google Scholar
• Huang J, Wu S, Barrera J, Matthews K, Pan D. 2005. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 122(3):421–434.
   PubMed Web of Science ®Google Scholar
• Jia J, Zhang W, Wang B, Trinko R, Jiang J. 2003. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 17(20):2514–2519.
   PubMed Web of Science ®Google Scholar
• Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. 1995. The Drosophila tumor suppressor gene wars encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9(5):534–646.
   PubMed Web of Science ®Google Scholar
• Kim S, Tachioka Y, Mori T, Hakoshima T. 2016. Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway. Sci Rep. 6:28488.
   PubMed Web of Science ®Google Scholar
• Kim W, Khan SK, Gvozdenovic-Jeremic J, Kim Y, Dahlman J, Kim H, Park O, Ishitani T, Jho EH, Gao B, et al. 2019. Hippo signaling interactions with wnt/β-catenin and Notch signaling repress liver tumorigenesis. J Clin Invest. 127(1):137–152.
   Web of Science ®Google Scholar
• Kim W, Khan SK, Liu Y, Xu R, Park O, He Y, Cha B, Gao B, Yang Y. 2018. Hepatic Hipoo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma. Gut. 67(9):1692–1703.
   PubMed Web of Science ®Google Scholar
• Koontz L, Liu-Chittenden Y, Yin F, Zheng Y, Yu J, Huang B, Chen Q, Wu S, Pan D. 2013. The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev Cell. 25(4):388–401.
   PubMed Web of Science ®Google Scholar
• Lai Z-C, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Ho L-L, Li Y. 2005. Control of cell proliferation and apoptosis by Mob as tumor suppressor, mats. Cell. 120(5):675–685.
   PubMed Web of Science ®Google Scholar
• Lee DH, Park JO, Kim TS, Kim SK, Kim TH, Lim MC, Park GS, Kim JH, Kuninaka S, Olson EN, et al. 2016. LATS-YAP/TAZ controls lineage specification by regulating TGFbeta signaling and Hnf4alpha expression during liver development. Nature Commun. 7:11961.
   PubMed Web of Science ®Google Scholar
• Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee S, Anders RA, Liu JO, Pan D. 2012. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26(12):1300–1305.
   PubMed Web of Science ®Google Scholar
• Lo Sardo F, Strano S, Blandino G. 2018. YAP and TAZ in lung cancer: oncogenic role and clinical targeting. Cancers. 10(5):137.
   Web of Science ®Google Scholar
• Luu AK, Schott CR, Jones R, Poon AC, Golding B, Hamed R, Deheshi B, Mutsaers A, Wood GA, Viloria-Petit AM. 2018. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression. BMC Vet Res. 14(1):365.
   PubMedGoogle Scholar
• Mahadevan MS, Amemiya C, Jansen G, Sabourin L, Baird S, Neville CE, Wormskamp N, Segers B, Batzer M, Lamerdin J, et al. 1993. Structure and genomic sequence of the myotonic dystrophy [DM] gene. Hum Mol Genet. 2(3):299–304.
   PubMed Web of Science ®Google Scholar
• Mohseni R, Karimi J, Tavilani H, Khodadadi I, Hashemnia M. 2019. Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Immunopharm Immunotox. 41(1):163–171.
   PubMed Web of Science ®Google Scholar
• Moon H, Cho K, Shin S, Kim DY, Han KH, Ro S. 2019. High risk of hepatocellular carcinoma development in fibrotic liver: role of the hippo-YAP/TAZ signaling pathway. Int J Mol Sci. 20(3):581.
   Web of Science ®Google Scholar
• Moroishi T, Hansen CG, Guan KL. 2015. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 15(2):73–79.
   PubMed Web of Science ®Google Scholar
• Noguchi S, Saito A, Horie M, Mikami Y, Suzuki HI, Morishita Y, Ohshima M, Abiko Y, Mattsson JSM, König H, et al. 2014. An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer. Clin Cancer Res. 20(17):4660–4672.
   PubMed Web of Science ®Google Scholar
• Osaki T, Hoshino S, Hoshino Y, Takagi S, Okumura M, Kadosawa T, Fujinaga T. 2006. Clinical pharmacokinetics of anti-angiogenic photodynamic therapy with benzoporphyrin derivative monoacid ring-A in dogs having naturally occurring neoplasms. J Vet Med Series A. 53(2):108–112.
   Google Scholar
• Osaki T, Takagi S, Hoshino Y, Okumura M, Kadosawa T, Fujinaga T. 2009. Efficacy of antivascular photodynamic therapy using benzoporphyrin derivative monoacid ring A (BPD-MA) in 14 dogs with oral and nasal tumors. J Vet Med Sci. 71(2):125–132.
   PubMed Web of Science ®Google Scholar
• Panciera T, Azzolin L, Fujimura A, Di Biagio D, Frasson C, Bresolin S, Soligo S, Basso G, Bicciato S, Rosato A, et al. 2016. Induction of expandable tissue-specific stem/progenitor cells through transient expression of YAP/TAZ. Cell Stem Cell. 19(6):725–737.
   PubMed Web of Science ®Google Scholar
• Panjehpour M, DeNovo RC, Petersen MG, Overholt BF, Bower R, Rubinchik V, Kelly B. 2002. Photodynamic therapy using Verteporfin (benzoporphyrin derivative monoacid ring A, BPD-MA) and 630 nm laser light in canine esophagus. Lasers Surg Med. 30(1):26–30.
   PubMed Web of Science ®Google Scholar
• Penning LC, Vrieling HE, Brinkhof B, Riemers FM, Rothuizen J, Rutteman GR, Hazewinkel HAW. 2007. A validation of 10 feline reference genes for gene expression measurements in snap-frozen tissues. Vet Immunol Immunopathol. 120(3-4):212–222.
   PubMed Web of Science ®Google Scholar
• Pepe-Mooney BJ, Dill MT, Alemany A, Ordovas-Montanes J, Matsushita Y, Rao A, Sen A, Miyazaki M, Anakk S, Dawson PA, et al. 2019. Single-cell analysis of the liver epithelium reveals dynamic heterogeneity and an essential role for Yap in homeostasis and regeneration. Cell Stem Cell. 25(1):23–38.
   PubMed Web of Science ®Google Scholar
• Peters IR, Peeters D, Helps CR, Day MJ. 2007. Development and application of multiple internal reference (housekeeper) gene assays for accurate normalization of canine gene expression studies. Vet Immunol Immnopathol. 117(1-2):55–66.
   PubMed Web of Science ®Google Scholar
• Planas-Paz L, Sun T, Pikiolek M, Cochran NR, Bergling S, Orsini V, Yang Z, Sigoillot F, Jetzer J, Syed M, et al. 2019. YAP, but not RSPO-LGT4/5 signaling in biliary epithelial cells promotes a ductular reaction in response to liver injury. Cell Stem Cell. 25(1):39–53.
   PubMed Web of Science ®Google Scholar
• Portela RF, Fadl-Alla BA, Pondenis HC, Byrum ML, Garret LD, Wycislo KL, Borst LB, Fan TM. 2014. Pro‐tumorigenic effects of transforming growth factor beta 1 in canine osteosarcoma. J Vet Intern Med. 28(3):894–904.
   PubMed Web of Science ®Google Scholar
• Rico C, Boerboom D, Paquet M. 2018. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours. Vet Comp Oncol. 16(4):630–635.
   PubMed Web of Science ®Google Scholar
• Saadeldin MK, Shawer H, Mostafa A, Kassem NM, Amleh A, Siam R. 2014. New genetic variants of LATS1 detected in urinary bladder and colon cancer. Front Genet. 5:425.
   PubMed Web of Science ®Google Scholar
• Sammarco A, Gomiero C, Sacchetto R, Beffagna G, Michieletto S, Orvieto E, Cavicchioli L, Gelain ME, Ferro S, Patruno M, et al. 2020. Wnt/β-catenin and Hippo pathway deregulation in mammary tumors of humans, dogs, and cats. Vet Pathol. 57(6):774–790.
   PubMed Web of Science ®Google Scholar
• Seo J, Kim J. 2018. Regulation of Hippo signaling by actin remodeling. BMB Rep. 51(3):151–156.
   PubMed Web of Science ®Google Scholar
• Sheng N, Wang Y, Xie Y, Chen S, Lu J, Zhang Z, Li M, Shan Q, Wu D, Zheng G, et al. 2019. High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer. J Cell Physiol. 234(8):13001–13013.
   PubMed Web of Science ®Google Scholar
• Sun X, Gao L, Chien HY, Li WC, Zhao J. 2013. The regulation and function of the NUAK family. J Mol. Edocrin. 51(2):R15–R22.
   PubMed Web of Science ®Google Scholar
• Tapon N, Harvey KF, Bell DW, Wahrer DCR, Schiripo TA, Haber DA, Hariharan IK. 2002. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell. 110(4):467–478.
   PubMed Web of Science ®Google Scholar
• Thompson BJ. 2020. YAP/TAZ: drivers of tumor growth, metastasis, and resistance to therapy. Bioeassays. 42(5):e1900162.
   PubMed Web of Science ®Google Scholar
• Tschaharganeh F, Chen X, Latzko P, Malz M, Gaida MM, Felix K, Ladu S, Singer S, Pinna F, Gretz N, et al. 2013. Yes-associated protein up-regulates Jagged-1 and activates the NOTCH pathway in human hepatocellular carcinoma. Gastroenterology. 144(7):1530–1542.e12.
   PubMed Web of Science ®Google Scholar
• Van Haele M, Moya I, Karaman R, Rens G, Snoeck J, Govaere O, Nevens F, Verslype C, Topal B, Monbaliu D, et al. 2019. YAP and YTAZ heterogeneity in primary liver cancer: an analysis of its prognostic and diagnostic role. Int J Mol Sci. 20(3):638.
   Web of Science ®Google Scholar
• Wada K, Itoga K, Okano T, Yonemura S, Sasaki H. 2011. Hippo pathway regulation by cell morphology and stress fibers. Development. 138(18):3907–3914.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhu X, Feng W, Yu Y, Jeong K, Guo W, Lu Y, Mills GB. 2016. Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm. Am J Cancer Res. 6(1):27–37.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PKS, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, et al. 2018. Comprehensive molecular characterization of the Hippo signaling pathway in cancer. Cell Rep. 25(5):1304–1317.
   PubMed Web of Science ®Google Scholar
• Weiler SME, Lutz T, Bissinger M, Sticht C, Kanub M, Gretz N, Schirmacher P, Breuhahn K. 2020. TAZ target gene ITAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Cancer Lett. 31:164–175.
   Google Scholar
• Wu S, Huang J, Dong J, Pan D. 2003. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell. 114(4):445–456.
   PubMed Web of Science ®Google Scholar
• Xu T, Wang W, Zhang S, Stewart RA, Yu W. 1995. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 121(4):1053–1063.
   PubMed Web of Science ®Google Scholar
• Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD. 2014. Hippo pathway activity influences liver cell fate. Cell. 157(6):1324–1338.
   PubMed Web of Science ®Google Scholar
• Yu F, Zhao B, Panupinthu N, Jewell JL, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, Fu XD, Mills GB, et al. 2012b. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 150(4):780–791.
   PubMed Web of Science ®Google Scholar
• Yu FX, Guan KL. 2013. The Hippo pathway: regulators and regulations. Genes Dev. 27(4):355–371.
   PubMed Web of Science ®Google Scholar
• Yu FX, Mo JS, Guan KL. 2012a. Upstream regulators of the Hippo pathway. Cell Cycle. 11(22):4097–4098. Dio: https://doi.org/10.4161/cc.22322.
   PubMed Web of Science ®Google Scholar
• Yuan WC, Pepe-Mooney B, Galli GG, Dill MT, Huang HT, Hao M, Wang Y, Liang H, Calogero RA, Camargo FD. 2018. NUAK2 is a critical YAP target in liver cancer. Nat Commun. 9(1):4834.
   PubMedGoogle Scholar
• Yuan WC, Pepe-Mooney B, Galli GG, Dill MT, Huang HT, Hao M, Wang Y, Liang H, Calogero RA, Camargo FD. 2018. NUAK2 is a critical YAP target in liver cancer. Natute Commun. 9:4834.
   PubMed Web of Science ®Google Scholar
• Zhang C, Bian M, Chen X, Jin H, Zhao S, Yang X, Shao J, Chen A, Guo Q, Zhang F, et al. 2018. Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF‐1α signaling. J Cell Biochem. 119(2):2258–2268.
   PubMed Web of Science ®Google Scholar
• Zhang K, Chang Y, Shi Z, Han X, Han Y, Yao Q, Hu Z, Cui H, Zheng L, Han T, et al. 2016. ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation. Sci Rep. 6:30029.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang J, Wang H, Fan L, Fan B, Zeng B, Tao J, Li X, Che L, Cigliano A, et al. 2018. Hippo cascade controls lineage commitment of liver tumors in mice and men. Am J Pathol. 188(4):995–1006.
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Tumaneng K, Wang C, Guan K. 2010. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP. Genes Dev. 24(1):72–85.
   PubMed Web of Science ®Google Scholar
• Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang C-Y, Chinnaiyan AM, et al. 2008. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22(14):1962–1971.
   PubMed Web of Science ®Google Scholar
• Zinsstag J, Schelling E, Waltner-Toews D, Tanner M. 2011. From “one medicine” to “one health” and systemic approaches to health and well-being. Prev Vet Med. 101(3-4):148–156.
   PubMed Web of Science ®Google Scholar